# Cyberattack Disrupts Boston Scientific's Manufacturing Operations

*Published September 2, 2026*
*Source: [https://cybersecuritynews.com/boston-scientific-cyberattack/](https://cybersecuritynews.com/boston-scientific-cyberattack/)*

## Executive Summary

Boston Scientific is addressing a cybersecurity incident affecting its global operations, particularly impacting manufacturing and order processing. The company is working with cybersecurity experts to manage the situation, with no unauthorized activity detected since the initial network outage on August 25.

## Article

Boston Scientific is dealing with a cybersecurity incident that has disrupted several aspects of its global operations. This disruption, detected on August 25, 2026, impacted the company's manufacturing, order processing, and product shipments due to a network outage affecting certain internal IT systems and business applications. The company has enlisted the expertise of CrowdStrike and other cybersecurity specialists to investigate, manage, and recover from the incident.

As of an update on August 30, Boston Scientific has not found any unauthorized activity in its systems since the initial detection. The impact has been limited to specific on-premises systems, sparing its cloud-based infrastructure. This suggests that the disruption is primarily affecting localized enterprise infrastructure rather than the company's broader cloud environment.

The systems affected include operational technology support functions and business applications essential for product manufacturing, processing customer orders, and shipping medical devices. While customers can still submit orders electronically through electronic data interchange and local applications, these orders are queued for fulfillment until normal processing and shipping resume.

Boston Scientific is making efforts to partially restore shipping for certain products in the week following the August 30 update. Full capacity for ordering and shipping will be resumed once the company confirms that the restored systems are fully operational. Concerns have been raised among hospitals, clinicians, suppliers, and patients who rely on Boston Scientific products, although the company reports no known impact on devices not connected to its network.

The company also provided updates regarding its Cardiac Rhythm Management device portfolio. Existing remotely monitored devices remain functional, and remote patient monitoring for pre-outage enrolled devices continues without disruption. However, new remote monitoring activations are currently affected, delaying the transmission of data to remote patient management systems. While newly implanted insertable cardiac monitors can record episodes, they cannot pair with patient mobile phones for remote transmission until system restoration. Boston Scientific is focusing on restoring systems that most significantly impact customer access, product delivery, and patient care. The company has not disclosed details about the threat actor, attack method, or a timeline for full recovery.